Elevated Histone Lactylation Mediates Ferroptosis Resistance in Endometriosis Through the METTL3‐Regulated HIF1A/HMOX1 Signaling Pathway
Advanced Science · 2025-08 · 12 (31)
DOI: 10.1002/advs.202408220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 10.06.2025. Verfasst von Zongwen Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China. Hauptthemen laut MEDLINE: Ferroptosis, Hypoxia-Inducible Factor 1, alpha Subunit, Endometriosis, Histones. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Heilongjiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Endometriosis (EMs) is a chronic gynecologic condition characterized by the growth of endometrial stromal and glandular tissue outside the uterine cavity of unknown etiology. Currently, ferroptosis resistance, increased glycolysis, and increased lactate production are identified in EMs. Histone lactylation is a lactate‐derived posttranslational modification that is recognized primarily for its role in epigenetic regulation. In this study, it is demonstrated that increased histone lactylation contributes to ferroptosis resistance in ectopic endometrial stromal cells (EESCs). Mechanistically, histone lactylation mediates ferroptosis resistance through the hypoxia‐inducible factor 1 alpha (HIF1A)/heme oxygenase 1 (HMOX1) signaling pathway, which is regulated by methyltransferase like 3 (METTL3). In vivo experiments reveal that combination therapy with 2‐deoxy‐D‐glucose (2‐DG) and erastin is more effective for the treatment of EMs. Together, the findings provide a theoretical basis for the pathogenesis of EMs and suggest that a combined treatment that inhibits histone lactylation and induces ferroptosis is an effective treatment for EMs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
ORCID-Profile: Zongwen Liang, Zongfeng Zhang
Förderung
- Natural Science Foundation of Heilongjiang Province
- National Natural Science Foundation of China
Zitieren
APA
Liang, Z., Liu, J., Gou, Y., Wang, H., Li, Z., Cao, Y., Zhang, H., Bai, R., & Zhang, Z. (2025). Elevated Histone Lactylation Mediates Ferroptosis Resistance in Endometriosis Through the METTL3‐Regulated HIF1A/HMOX1 Signaling Pathway. Advanced Science, 12(31). https://doi.org/10.1002/advs.202408220
Vancouver
Liang Z, Liu J, Gou Y, Wang H, Li Z, Cao Y, et al. Elevated Histone Lactylation Mediates Ferroptosis Resistance in Endometriosis Through the METTL3‐Regulated HIF1A/HMOX1 Signaling Pathway. Advanced Science. 2025;12(31). doi:10.1002/advs.202408220
BibTeX
@article{Liang2025,
author = {Liang, Zongwen and Liu, Jinming and Gou, Yanling and Wang, Honglin and Li, Zhi and Cao, Yingying and Zhang, Huiyan and Bai, Ruru and Zhang, Zongfeng},
title = {Elevated Histone Lactylation Mediates Ferroptosis Resistance in Endometriosis Through the METTL3‐Regulated HIF1A/HMOX1 Signaling Pathway},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {31},
doi = {10.1002/advs.202408220}
}
EUVIMED